Back
Verve Therapeutics Vs. Immuneering Industry Stock Comparison
Sell
25
VERV
Verve Therapeutics
Last Price:
4.85
Seasonality Move:
-11.16%
Sell
42
IMRX
Immuneering
Last Price:
2.10
Seasonality Move:
-27.69%
Sell
25
Verve Therapeutics (VERV)
is a Sell
Is Verve Therapeutics a Buy, Sell or Hold?
- The current Verve Therapeutics [VERV] share price is $4.85. The Score for VERV is 25, which is 50% below its historic median score of 50, and infers higher risk than normal.
- VERV is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
42
Immuneering (IMRX)
is a Sell
Is Immuneering a Buy, Sell or Hold?
- The current Immuneering [IMRX] share price is $2.10. The Score for IMRX is 42, which is 16% below its historic median score of 50, and infers higher risk than normal.
- IMRX is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
VERV Stock Price Chart
What is Verve Therapeutics's stock price today?
-
The Verve Therapeutics share price today is $4.85
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and VERV is experiencing buying pressure, which is a positive indicator for future bullish movement.
IMRX Stock Price Chart
What is Immuneering's stock price today?
-
The Immuneering share price today is $2.10
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and IMRX is experiencing selling pressure, which indicates risk of future bearish movement.
VERV Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.23 | Sell |
Relative Strength Index (14 RSI): | 40.26 | Sell |
Chaikin Money Flow: | 1039980 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (5.04 - 6.28) | Sell |
Bollinger Bands (100): | (4.83 - 6.53) | Sell |
IMRX Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.02 | Sell |
Relative Strength Index (14 RSI): | 54.77 | Buy |
Chaikin Money Flow: | -197229 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (1.84 - 2.1) | Buy |
Bollinger Bands (100): | (1.13 - 2.29) | Buy |
VERV Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 4.91 | Sell |
20-day SMA: | 5.65 | Sell |
50-day SMA: | 5.36 | Sell |
200-day SMA: | 7.32 | Sell |
8-day EMA: | 4.99 | Sell |
20-day EMA: | 5.35 | Sell |
50-day EMA: | 5.47 | Sell |
200-day EMA: | 7.4 | Sell |
IMRX Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 1.94 | Buy |
20-day SMA: | 1.93 | Buy |
50-day SMA: | 2.22 | Sell |
200-day SMA: | 2.26 | Sell |
8-day EMA: | 2 | Buy |
20-day EMA: | 1.98 | Buy |
50-day EMA: | 1.97 | Buy |
200-day EMA: | 2.71 | Sell |
Verve Therapeutics Earnings Growth & VERV Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.08 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.81 per share, and a decrease next year of $0.48 per share.
Immuneering Earnings Growth & IMRX Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.17 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.01 per share, and an increase next year of $0.22 per share.
Verve Therapeutics Technical Analysis
Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | |
---|---|---|---|---|---|---|---|---|---|---|
Nov | ||||||||||
11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | 21 | 22 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Immuneering Technical Analysis
Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | |
---|---|---|---|---|---|---|---|---|---|---|
Nov | ||||||||||
11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | 21 | 22 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |